C12N 2710/16363
By chemical treatment
Official title: by chemical treatment
C12N2710/16363 (By chemical treatment) appears on 4 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 5
- Assignees
- 2
- Inventors
- 5
- Latest grant
- 12 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof12 Aug 2025US 12,385,068 B2Boehringer Ingelheim Animal Health USA Inc.
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof23 Aug 2022US 11,421,249 B2Boehringer Ingelheim Animal Health USA Inc.
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof3 Nov 2020US 10,822,620 B2Boehringer Ingelheim Animal Health USA Inc.
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof18 Jun 2019US 10,323,257 B2Boehringer Ingelheim Animal Health USA Inc.
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof30 Oct 2025US 2025/0333766 A1Boehringer Ingelheim Animal Health USA Inc.
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof8 Jun 2023US 2023/0175017 A1Boehringer Ingelheim Animal Health USA Inc.
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof14 Jan 2021US 2021/0010033 A1Boehringer Ingelheim Animal Health USA Inc.
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof15 Aug 2019US 2019/0249196 A1Boehringer Ingelheim Animal Health USA Inc.
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof14 Jun 2018US 2018/0163230 A1Merial Limited
Most cited
By later US patents
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof6US 10,323,257 B2Boehringer Ingelheim Animal Health USA Inc. · 2019
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof3US 10,822,620 B2Boehringer Ingelheim Animal Health USA Inc. · 2020